Fairchem Organics PAT jumps 7.5x YoY to ₹10 Cr as OPM expands to 10.1% from 4%

Fairchem Organics' standalone (its only basis — no subsidiaries) Q1 FY27 revenue from operations rose 34.4% YoY and 50.6% QoQ to ₹176.15 Cr, while PAT surged 753% YoY and 171% QoQ to ₹10.01 Cr (EPS ₹7.95, against ₹0.90 a year ago and ₹2.85 last quarter). Operating margin (PBT before finance cost and depreciation, over revenue) expanded to ~10.1% from 3.98% YoY and 6.87% QoQ, and net margin rose to 5.69% from 0.89% YoY — a clear margin-expansion, not just a topline, story. No exceptional items sit in either the current or year-ago quarter, so the growth is entirely operating.

The margin bridge is led by raw materials: cost of materials plus inventory movement fell to about 77.3% of revenue from 81.5% a year earlier, a roughly 4.2-point improvement, pointing to better spreads on Oleo Chemicals/Nutraceutical intermediates rather than one-off cost relief. Employee cost (3.83% of revenue vs 4.59% YoY) and power & fuel (3.96% vs 5.07% YoY) also diluted as revenue scaled, consistent with operating leverage on largely fixed costs. Finance cost rose in absolute terms (₹1.84 Cr vs ₹1.01 Cr YoY) but shrank as a share of the much larger revenue base.

The stock went into the print at ₹731, up 22.4% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.

Single reportable segment (Speciality Chemicals) — company has no subsidiary/associate/JV

On management's own prior guidance from the Q3 FY26 call — that the worst quarter was behind them, with sequential volume/value growth and gradual margin gains building to 'better numbers' only by H2 FY27 — this print is ahead of that timeline: margin and profit gains this large have already shown up in Q1. We found no formal Street consensus or brokerage preview for this print (Fairchem carries thin analyst coverage), so vs-Street is unknown rather than a miss/beat call. Company press release commentary beyond the bare board-outcome letter was not available for this filing. Corporate context this quarter includes a ₹1/share dividend recommended alongside FY26 results in May, the FY26 annual report/AGM notice and BRSR filed in June, and the trading window closing ahead of this result — none of which bear directly on the P&L move.